Nanjing Wanpin Commercial Management Co., Ltd. announced that it will receive CNY 7,000,000 in an equity round of funding on December 28, 2022. The transaction will include participation from Fujian Wanchen Biotechnology Co., Ltd for CNY 3,570,000; Huainan Shengyu Enterprise Management Co., Ltd for CNY 611,800; Huainan Huixiang Enterprise Management Co., Ltd. for CNY 53,200; Xinghua Dewen Management Consulting Co., Ltd. for CNY 546,000; Xinghua Geometry Management Consulting Co., Ltd. for CNY 84,000; Wang Zening for CNY 1,715,000; Song Xiaofei for CNY 210,000; and Sun Aidi for CNY 210,000. The transaction has been approved in the twenty-eighth meeting of the third board of directors and the twenty-sixth meeting of the third board of supervisors.

After the completion of the transaction, registered capital will be increased from CNY 1,000,000 to CNY 8,000,000.